MedTrace Logo

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia

NCT02849184 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2019-08-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effectiveness and safety of suvorexant versus placebo on sleep pressure and circadian rhythm in hypertensives with insomnia.

Conditions

Interventions

DRUG

suvorexant

Suvorexant (20mg for 64 years or younger; 15mg for 65 years or older) once daily before bedtime.

OTHER

Placebo

Placebo once daily before bedtime.

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Satt Co.,Ltd

    collaborator UNKNOWN

  • Jichi Medical University

    lead OTHER

Principal Investigators

  • Kazuomi Kario, MD, PhD · Jichi Medical University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-17
Primary Completion
2017-10-31
Completion
2018-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02849184 on ClinicalTrials.gov